Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact Anayansi Miloud to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of Southern California/Norris Cancer Hospital, Los Angeles, California, 90033
- Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, 90048
- St. Jude Medical Center, Virginia K. Crosson Cancer Center, Fullerton, California, 92801
- South Orange County Surgical Medical Group, Laguna Hills, California, 92653
- Moores UC San Diego Cancer Center (UCSD), San Diego, California, 92093
- University of California, San Francisco (UCSF), Hellen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115
-
Oregon
- OHSU Knight Cancer Institute, Portland, Oregon, 97239
-
Colorado
- University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, 80045
-
Washington
- Multicare Health System-Research Institute, Tacoma, Washington, 98405
- Swedish Cancer Institute Research, Seattle, Washington, 98104
-
Texas
- Clinical Trials of Texas, Inc, San Antonio, Texas, 78229
- Brooke Army Medical Center (now SAMMC), Ft. Sam Houston, Texas, 78234
- UT Southwestern Medical Center / Simmons Comprehensive Cancer Center, Dallas, Texas, 75390
- Baylor College of Medicine, Houston, Texas, 77030
- University of Texas MD Anderson Cancer Center, Houston, Texas, 77030
-
Kansas
- Cancer Center of Kansas, Wichita, Kansas, 67214
-
North Dakota
- St. Alexius Medical Center, Mid Dakota Clinic, PC, Bismarck, North Dakota, 58501
-
Wisconsin
- Medical College of Wisconsin Department of Surgery Froedtert Hospital and Cancer Center, Milwaukee, Wisconsin, 52336
-
Louisiana
- Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, 70809
-
Tennessee
- The West Clinic, Memphis, Tennessee, 38120
-
Illinois
- Northwestern University Feinberg School of Medicine, Lynn Sage Comprehensive Breast Center, Chicago, Illinois, 60611
- Northwestern University Feinberg School of Medicine, Lynn Sage Comprehensive Breast Center, Chicago, Illinois, 60611
-
Alabama
- Alabama Oncology, Bessemer, Alabama, 35022
-
Kentucky
- James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, 40202
-
Lille
- Centre Oscar Lambret, Cédex, Lille, 59020
-
Ukraine
- Lviv State Regional Treatment and Diagnostics Oncology Center, Department of Chemotherapy, Lviv, 79031
- Public Institution Zaporizhia Regional Clinical Oncology Center within Zaporizhia Regional Council, Zaporizhia, 69040
- Public Institution Zaporizhia Regional Clinical Oncology Center within Zaporizhia Regional Council, Zaporizhia, 69040
- Chernivtsi Regional Clinical Oncology Center, Day Care Unit, Chernivtsi, 58013
- State Institution: S.P. Grigoriev Institute of Medical Radiology Under the Academy of Medical Sciences of Ukraine, Kharkiv, 61024
- State Institution: S.P. Grigoriev Institute of Medical Radiology Under the Academy of Medical Sciences of Ukraine, Kharkiv, 61024
- Dnipropetrovsk City Multispecialty Clinical Hospital #4/Dnipropetrovsk Regional Council, Department of Chemotherapy, Dnipropetrovsk, 49102
-
Germany
- Nationales Centrum für Tumorerkrankungen (NCT), Gynäkologische Onkologie, Heidelberg, 69120
- Klinikum Stuttgart, Krankenhaus Bad Cannstatt, Frauenklinik, Stuttgart, 70374
- Universität Marburg, Marburg, 35043
-
Ramat Gan
- Sheba Medical Centre, Tel Hasomer, Ramat Gan, 52621
-
Kyivskyi District
- Kharkiv Regional Clinical Oncology Center, Day Care Unit, Kharkiv, Kyivskyi District, 61070
Powered by
SC CTSI